Clinical and Molecular Prognostic Factors and Targeted Therapy Outcomes in Colorectal Cancer with Bone and Brain Metastases: A Multicenter Retrospective Turkish Oncology Group Study
Current Oncology · 17.11.2026 · 33 (11) · 712
DOI: 10.3390/curroncol33110712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.11.2026. Verfasst von Kadriye Başkurt und 30 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bone and brain metastases are rare in colorectal cancer, and prior studies have treated metastasis as a fixed baseline characteristic. We conducted a multicenter retrospective study of patients with colorectal cancer and bone and/or brain metastases at Turkish Oncology Group centers (May 2011 to September 2025). In multivariable Cox models, the opposite rare-site metastasis and post-metastasis targeted therapy were modeled as time-dependent covariates. Among 188 patients, 139 (73.9%) had bone-first, 33 (17.6%) brain-first, and 16 (8.5%) synchronous disease. Median overall survival was 13.6 months (95% CI 11.6 to 16.4), with no difference by phenotype (p = 0.705). Opposite-site involvement was associated with higher mortality in the bone-metastasis (aHR 2.149, p = 0.006) and brain-metastasis (aHR 2.076, p = 0.018) cohorts, reflecting brain metastasis developing during follow-up in the former and bone metastasis present at diagnosis in the latter. Carcinoembryonic antigen and neutrophil-to-lymphocyte ratio were independently prognostic (both p < 0.01). Anti-EGFR (aHR 0.356, p = 0.001) and anti-VEGF therapy (aHR 0.471, p = 0.005) were associated with lower mortality in patients with bone metastasis but not in those with brain metastasis. Brain metastasis developing in patients with bone metastases carries independent prognostic weight, while targeted-therapy associations in brain metastasis remain inconclusive.
Zitieren
APA
Başkurt, K., Uyar, G. C., Yeşilbaş, E., Büyükşimşek, M., Çamöz, E. S., Yılmaz, E., Hacıbekiroğlu, İ., Müsri, F. Y., Tuzcu, T. U., Kahveci, G. B., Can, L. Ş., Türk, H. M., Tekin, M. D., Şahbazlar, M., Günaltili, M., Demirci, N. S., Ersoy, M., Majidova, N., Avcı, N., …, & Sütcüoğlu, O. (2026). Clinical and Molecular Prognostic Factors and Targeted Therapy Outcomes in Colorectal Cancer with Bone and Brain Metastases: A Multicenter Retrospective Turkish Oncology Group Study. Current Oncology, 33(11), 712. https://doi.org/10.3390/curroncol33110712
Vancouver
Başkurt K, Uyar GC, Yeşilbaş E, Büyükşimşek M, Çamöz ES, Yılmaz E, et al. Clinical and Molecular Prognostic Factors and Targeted Therapy Outcomes in Colorectal Cancer with Bone and Brain Metastases: A Multicenter Retrospective Turkish Oncology Group Study. Current Oncology. 2026;33(11):712. doi:10.3390/curroncol33110712
BibTeX
@article{Bakurt2026,
author = {Başkurt, Kadriye and Uyar, Galip Can and Yeşilbaş, Enes and Büyükşimşek, Mahmut and Çamöz, Elif Sertesen and Yılmaz, Emre and Hacıbekiroğlu, İlhan and Müsri, Fatma Yalçın and Tuzcu, Tuba Uğur and Kahveci, Gizem Bakır and Can, Lamia Şeker and Türk, Hacı Mehmet and Tekin, Melike Dönmez and Şahbazlar, Mustafa and Günaltili, Murat and Demirci, Nebi Serkan and Ersoy, Mustafa and Majidova, Nargiz and Avcı, Nilüfer and Aydın, Sabin Göktaş and Taş, Semra and Taşköylü, Burcu Yapar and Yıldızhan, Sezin and Karabulut, Senem and Şakalar, Teoman and Telli, Tuğba Akın and Bükün, Hülya Odabaşı and Şahin, Ahmet Bilgehan and Öksüzoğlu, Ömür Berna Çakmak and Yücel, Kadriye Bir and Sütcüoğlu, Osman},
title = {Clinical and Molecular Prognostic Factors and Targeted Therapy Outcomes in Colorectal Cancer with Bone and Brain Metastases: A Multicenter Retrospective Turkish Oncology Group Study},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {11},
pages = {712},
doi = {10.3390/curroncol33110712}
}
EUVIMED